| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.99M | - | |
| Other | 21.6K | $1.42M | - | |
| Other | 15.4K | $1.01M | -5,538 | |
| Dir | 8.0K | $525.6K | - | |
| Dir | 8.0K | $525.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 6,564 | $13.16 | $86,382.24 | -7.1% | -18.3% | -73.5% | |
| Nov 16, 2021 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 6,741 | $13.16 | $88,711.56 | -4.4% | -18.3% | -73.5% | |
| Nov 16, 2021 | Robin Howard W58 | President &CEO | Sell | 42,773 | $13.16 | $562,892.68 | -8.3% | -18.3% | -73.5% | |
| Sep 22, 2021 | Curet Myriam56 | Director | Sell | 3,665 | $17.78 | $65,163.70 | -12.4% | -13.6% | -81.9% | |
| Sep 22, 2021 | Chess Robert84 | Director | Sell | 4,600 | $17.94 | $82,524.00 | -1.6% | -13.6% | -81.9% | |
| Sep 22, 2021 | Ajer Jeffrey Robert58 | Director | Sell | 3,665 | $17.78 | $65,163.70 | -10.1% | -13.6% | -81.9% | |
| Sep 9, 2021 | Chess Robert84 | Director | Sale+OE | 18,279 | $16.01 | $292,669.58 | -3.2% | -19.3% | -76.3% | |
| Aug 17, 2021 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 10,867 | $13.76 | $149,480.61 | -2.2% | -2.4% | -65.5% | |
| Aug 16, 2021 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 7,662 | $13.83 | $105,965.46 | -3.5% | -3.1% | -66.0% | |
| Aug 16, 2021 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 1,910 | $13.83 | $26,415.30 | -2.6% | -3.1% | -66.0% |